The global Cancer Biopsy Instruments and Kits market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Cancer Biopsy Instruments and Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biopsy Instruments and Kits. This report contains market size and forecasts of Cancer Biopsy Instruments and Kits in global, including the following market information:
- Global Cancer Biopsy Instruments and Kits Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global Cancer Biopsy Instruments and Kits Market Sales, 2018-2023, 2024-2032, (K Units)
- Global top five Cancer Biopsy Instruments and Kits companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Cancer Biopsy Instruments Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Biopsy Instruments and Kits include QIAGEN NV, Illumina, Inc., Becton, Dickinson and Company, Myriad Genetics, Thermo Fisher Scientific, Inc., BIOCEPT, INC., ANGLE plc, Hologic, Inc. and Lucence Diagnostics Pte. Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Cancer Biopsy Instruments and Kits manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Biopsy Instruments and Kits Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cancer Biopsy Instruments and Kits Market Segment Percentages, by Type, 2022 (%)
- Cancer Biopsy Instruments
- Cancer Biopsy Kits
Global Cancer Biopsy Instruments and Kits Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cancer Biopsy Instruments and Kits Market Segment Percentages, by Application, 2022 (%)
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Others
Global Cancer Biopsy Instruments and Kits Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cancer Biopsy Instruments and Kits Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cancer Biopsy Instruments and Kits revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Cancer Biopsy Instruments and Kits revenues share in global market, 2022 (%)
- Key companies Cancer Biopsy Instruments and Kits sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Cancer Biopsy Instruments and Kits sales share in global market, 2022 (%)
key players include:
- QIAGEN NV
- Illumina, Inc.
- Becton, Dickinson and Company
- Myriad Genetics
- Thermo Fisher Scientific, Inc.
- BIOCEPT, INC.
- ANGLE plc
- Hologic, Inc.
- Lucence Diagnostics Pte. Ltd.
- Danaher Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Biopsy Instruments and Kits, market overview.
Chapter 2: Global Cancer Biopsy Instruments and Kits market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Biopsy Instruments and Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Biopsy Instruments and Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Biopsy Instruments and Kits capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
